The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...
Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of ...
Adam Elinoff will become Aglient Technologies' CFO on Nov. 17. (courtesy photo) Agilent Technologies, a supplier of laboratory medical equipment to the biotechnology industry that is based in Santa ...
Vir Biotechnology, Inc. (($VIR)) announced an update on their ongoing clinical study. Vir Biotechnology, Inc. is conducting a Phase 1 study titled ...
Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks. In this wonky industry, encouraging results from a clinical trial can turn ...
BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.
MAIA Biotechnology, Inc. ((MAIA)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...
Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...
The 18,500-square-foot building offers industry-grade training for biotech technicians and is part of McCord's efforts to brand Generation Park as a premier life sciences hub in Houston.
The iShares Biotechnology ETF (IBB) provides exposure to healthcare innovation with a focus on the biggest firms by market ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
Doha's healthcare expenditure is slated to touch $13bn by 2030, showing a 14% compound annual growth rate (CAGR) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results